At the start of the COVID-19 pandemic, Uruguay had some of the lowest infection rates in Latin America. On June 30, 2020, Bloomberg reported that while its bordering country Brazil had 1.34 million total cases, Uruguay had only 932 cases. Now, about a year later, COVID-19 vaccination rates in Uruguay are among the highest in Latin America, with more than four million doses received by citizens.
Impacts of COVID-19 in Uruguay
As a result of the COVID-19 pandemic, Uruguay’s unemployment rates have increased dramatically. In March 2020, more than 86,000 citizens applied for unemployment insurance. Before the pandemic, applications averaged 11,000 per month. A complete vaccination rollout is critical for Uruguay’s citizens to return to work.
Uruguay has already started to reopen businesses, but since only about half of the country has been vaccinated, infections are increasing. In order to avoid another shutdown of the country and another fall in employment, efforts for COVID-19 vaccination in Uruguay need to receive continued support and funding.
On June 8, 2021, Uruguay released reports about the success of the Sinovac Biotech vaccine along with more information about the Pfizer vaccine. According to Reuters, Sinovac’s COVID-19 vaccine was more than 90% successful in preventing intensive hospitalization and death. Further, the vaccine reduced COVID-19 infections by 61%. The Pfizer vaccine was 94% effective in preventing intensive care hospitalization and death and 78% effective in reducing COVID-19 infections.
Increasing COVID-19 Cases in Uruguay
COVID-19 vaccination in Uruguay has been very successful so far, with 52% of the population given at least one dose of either the Sinovac, Pfizer or AstraZeneca vaccines. Despite this success, Uruguay is also facing a crisis as COVID-19 infections skyrocket.
For several weeks in late May and early June 2021, Uruguay had one of the highest global COVID-19 related death rates per capita. In the last week of May 2021, the small nation of just 3.5 million residents recorded an average of 55 deaths per day. Many experts blame public health guidelines that have become increasingly lax as the pandemic continues. Not enough of the population is vaccinated to support the less restrictive public health measures and Uruguay is now rushing to further increase its vaccination rates.
The United States is working with COVAX to improve the vaccine rollout around the world, which might help Uruguay. COVAX is led by the Coalition for Epidemic Preparedness Innovations, the World Health Organization, Gavi and UNICEF. Its goal is to vaccinate at least 20% of every participating country’s population by the end of 2021. NPR notes that it may not be able to meet this goal due to the global vaccine shortage. Wealthier countries that have already secured enough vaccines for their populations need to step in to help struggling countries with vaccine donations.
Supporting the Global Vaccine Rollout
According to the Stanford Social Innovation Review, there are many ways in which organizations can support the global vaccine rollout. First, it is important that there is a level of trust between citizens and the distributors of the vaccine. Many people are hesitant about vaccines because they do not necessarily trust the intentions of vaccine developers. With trustworthy messengers such as community leaders and trusted organizations working to combat vaccine hesitancy, people may be less reluctant to receive a vaccine.
Second, the delivery of vaccinations requires innovation. A major problem for those in rural and low-income areas is a lack of access. Many cannot travel far to receive a dose, therefore, investing in creative ways to deliver vaccines to remote locations is important. For example, implementing mobile vaccination sites.
Finally, supporting the training of local healthcare workers in contact tracing, COVID-19 education and vaccination means more people will be qualified to address the pandemic. Thus, COVID-19 vaccination in Uruguay can continue long after global organizations leave the area, ensuring efforts are sustainable. With private and public sector groups working together, combating the COVID-19 pandemic and improving global health is not a distant goal.
– Jessica Li